Skip to main content
. 2013 Jul 9;2013(7):CD006910. doi: 10.1002/14651858.CD006910.pub2

IMC‐383/NCT00913835.

Trial name or title A study of liposomal doxorubicin with or without IMC‐3G3 in platinum‐refractory or resistant advanced ovarian cancer
Methods Phase II open‐label RCT
Participants 125 women with ROC
Interventions IMC‐383 + LD versus LD
Outcomes Primary: PFS
Secondary: OS, ORR, duration of response, SAE
Starting date Jun 2009
Contact information ClinicalTrials@ ImClone.com
Notes End Date: Oct 2011